Uveoxine 300 Super is indicated primarily for the treatment of bovine respiratory disease associated with pasteurella haemolytica. In addition a wide range of organisms including pasteurella spp, coryne-bacterium pyogenes, staphylococcus aureus and certain mycoplasma are known to be sensitive in vitro to oxytetracycline.

-Use is contraindicated in animals suffering from cardiac, hepatic or renal disease, where there is a possibility of gastrointestinal ulceration or bleeding or where there is hypersensitivity to the product.

-Avoid use in dehydrated, hypovolemic or hypotensive animals as there is potential risk of increased renal toxicity.

-Do not administer other NSAIDs concurrently or within 24 hours of each other.

-Concurrent use of potentially nephrotoxic drugs should be avoided.

-Use in any animals less than 6 weeks of age or aged animals may involve additional risk. If such use can't be avoided, animals may require a reduced dosage and careful clinical management.

Deep intramuscular injection in cattle.

The recommended dosage is 1 ml/10 kg b.wt (equivalent to 30 mg/kg oxytetracycline and 2 mg/kg flunixin) on a single occasion.

Maximum volume per injection site: 15 ml. If concurrent treatment is administered, use a separate injection site.

-Avoid intra-arterial injection.

- If concurrent treatment is administered use a separate injection site.

Meat: 35 days after the last treatment.

Not for use in cattle producing milk for human consumption.

Store at temp below 30º C, protected from light .